Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2021
A Phase I Study of the Combination of Pexidartinib and Sirolimus to Target Tumor-Associated Macrophages in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors
Gulam A Manji, Brian A Van Tine, Shing M Lee, et al.
Journal of Neurotrauma
|
October 7, 2009
The citicoline brain injury treatment (COBRIT) trial: design and methods
Ross Zafonte, William T Friedewald, Shing M Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2022
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials
Joseph M Unger, Riha Vaidya, Kathy S Albain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 30, 2010
Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma
Jia Ruan, Peter Martin, Richard R Furman, et al.
Journal of the National Cancer Institute
|
November 21, 2002
Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer
Hsueh-Wei Chang, Shing M Lee, Steven N Goodman, et al.
The Journal of Urology
|
March 3, 2020
A Phase I Trial of Intravesical Cabazitaxel, Gemcitabine and Cisplatin for the Treatment of Nonmuscle Invasive bacillus Calmette-Guérin Unresponsive or Recurrent/Relapsing Urothelial Carcinoma of the Bladder
Guarionex J DeCastro, Wilson Sui, Jamie S Pak, et al.
Breast Cancer Research and Treatment
|
July 2, 2021
Diffuse optical tomography breast imaging measurements are modifiable with pre-surgical targeted and endocrine therapies among women with early stage breast cancer
Julia E McGuinness, Mirella L Altoe, Alessandro Marone, et al.
The Oncologist
|
March 18, 2026
Phase 2 Study of Azacitidine plus Pembrolizumab as Second-Line Treatment in Patients with Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Rachael A Safyan, Ruth A White, Tamas A Gonda, et al.
Journal of the American Medical Informatics Association : JAMIA
|
December 1, 2020
Towards clinical data-driven eligibility criteria optimization for interventional COVID-19 clinical trials
Jae Hyun Kim, Casey N Ta, Cong Liu, et al.
Journal of Clinical and Translational Science
|
April 27, 2026
Return of results is important to heterogeneous research participants: A single-site survey
Sheila M O'Byrne, Ismael Castaneda, Rayheann-NaDeja Collins, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2021
A Phase I Study of the Combination of Pexidartinib and Sirolimus to Target Tumor-Associated Macrophages in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors
Gulam A Manji, Brian A Van Tine, Shing M Lee, et al.
Journal of Neurotrauma
|
October 7, 2009
The citicoline brain injury treatment (COBRIT) trial: design and methods
Ross Zafonte, William T Friedewald, Shing M Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2022
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials
Joseph M Unger, Riha Vaidya, Kathy S Albain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 30, 2010
Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma
Jia Ruan, Peter Martin, Richard R Furman, et al.
Journal of the National Cancer Institute
|
November 21, 2002
Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer
Hsueh-Wei Chang, Shing M Lee, Steven N Goodman, et al.
The Journal of Urology
|
March 3, 2020
A Phase I Trial of Intravesical Cabazitaxel, Gemcitabine and Cisplatin for the Treatment of Nonmuscle Invasive bacillus Calmette-Guérin Unresponsive or Recurrent/Relapsing Urothelial Carcinoma of the Bladder
Guarionex J DeCastro, Wilson Sui, Jamie S Pak, et al.
Breast Cancer Research and Treatment
|
July 2, 2021
Diffuse optical tomography breast imaging measurements are modifiable with pre-surgical targeted and endocrine therapies among women with early stage breast cancer
Julia E McGuinness, Mirella L Altoe, Alessandro Marone, et al.
The Oncologist
|
March 18, 2026
Phase 2 Study of Azacitidine plus Pembrolizumab as Second-Line Treatment in Patients with Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Rachael A Safyan, Ruth A White, Tamas A Gonda, et al.
Journal of the American Medical Informatics Association : JAMIA
|
December 1, 2020
Towards clinical data-driven eligibility criteria optimization for interventional COVID-19 clinical trials
Jae Hyun Kim, Casey N Ta, Cong Liu, et al.
Journal of Clinical and Translational Science
|
April 27, 2026
Return of results is important to heterogeneous research participants: A single-site survey
Sheila M O'Byrne, Ismael Castaneda, Rayheann-NaDeja Collins, et al.
Page
of 7